Connection
Edward Havranek to Hypertrophy, Left Ventricular
This is a "connection" page, showing publications Edward Havranek has written about Hypertrophy, Left Ventricular.
|
|
Connection Strength |
|
 |
|
 |
|
0.803 |
|
|
|
-
Havranek EP, Froshaug DB, Emserman CD, Hanratty R, Krantz MJ, Masoudi FA, Dickinson LM, Steiner JF. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med. 2008 Oct; 121(10):870-5.
Score: 0.303
-
Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, Estacio RO, Dickinson LM, Steiner JF. Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol. 2008 Jul-Aug; 41(4):342-50.
Score: 0.291
-
Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. Am Heart J. 2003 Jun; 145(6):993-8.
Score: 0.209